Research Analysts’ downgrades for Wednesday, October 11th:

Galmed Pharmaceuticals (NASDAQ:GLMD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel. “

Golar LNG Partners (NASDAQ:GMLP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Golar LNG Partners LP is a limited partnership primarily focused on owning and operating floating storage and regasification units (or FSRUs) and LNG carriers under long-term charters. Golar LNG Partners LP is based in Hamilton, Bermuda. “

Green Bancorp (NASDAQ:GNBC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Green Bancorp, Inc. is a bank holding company for Green Bank, N.A. The Bank is a nationally chartered commercial bank providing commercial and private banking services. It offers deposit accounts comprising demand, savings, money market, and time accounts. The Company also provides loans, including residential real estate loans, home equity loans, home equity lines of credit, installment loans, unsecured and secured personal lines of credit, overdraft protection and letters of credit. It also provides a range of online banking solutions; and extended drive-through hours, and ATMs, as well as banking through telephone, mail, and personal appointment. Green Bancorp, Inc. is headquartered in Houston, Texas. “

Canada Goose Holdings (NYSE:GOOS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Canada Goose is a global outerwear brand. Canada Goose is a designer, manufacturer, distributor and retailer of premium outerwear for men, women and children. The Company’s jackets are sold in 36 countries around the world, including in two owned retail stores and four e-commerce stores. “

Granite Point Mortgage Trust (NASDAQ:GPMT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Granite Point Mortgage Trust Inc. focuses primarily on directly originating, investing in and managing senior floating-rate commercial mortgage loans and other debt and debt-like commercial real estate investments. Granite Point Mortgage Trust Inc. is headquatered in New York, United States. “

Grifols, (NASDAQ:GRFS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain. “

G1 THERAPEUTICS (NASDAQ:GTHX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company’s product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC. “

Gray Television (NYSE:GTN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Gray Television is a communications company headquartered in Atlanta, Georgia, and currently operates 15 CBS-affiliated television stations, seven NBC-affiliated television stations, seven ABC-affiliated television stations and four daily newspapers. “

Triple-S Management Corporation (NYSE:GTS) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Triple-S Management Corporation is an independent licensee of the Blue Cross Blue Shield Association. It is the largest managed care company in Puerto Rico, serving approximately one million members across all regions. Triple-S offers a broad portfolio of managed care and related products in the commercial, Medicare and Reform (similar to Medicaid) markets. In addition to its managed care business, Triple-S provides life and property and casualty insurance in Puerto Rico. “

GTT Communications (NYSE:GTT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “GTT Communications, Inc. offers cloud networking; high bandwidth IP transit for content delivery and hosting as well as network-to-network carrier interconnects solutions and data connectivity solutions. The company’s network consists of a layer 2 switched Ethernet and IP transit or dedicated internet access. It operates primarily in North America, Europe and Asia. GTT Communications, Inc., formerly known as Global Telecom & Technology, Inc., is headquartered in McLean, Virginia. “

Hi-Crush Partners (NYSE:HCLP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Hi-Crush Partners LP engages in the production of monocrystalline sand, a specialized mineral that is used as a proppant to enhance the recovery rates of hydrocarbons from oil and natural gas wells. The Company reserves consist of Northern White sand, a resource existing in Wisconsin and limited portions of the upper Midwest region of the United States. It owns, operates and develops sand reserves and related excavation and processing facilities. Hi-Crush Partners LP is based in Houston, Texas. “

H&E Equipment Services (NASDAQ:HEES) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “H&E Equipment Services, Inc. is one of the largest integrated equipment services companies in the United States with full-service facilities throughout the Intermountain, Southwest, Gulf Coast & Southeast regions of the United States. The Company is focused on heavy construction & industrial equipment and rents, sells & provides parts & service support for four core categories of specialized equipment they are hi-lift or aerial platform equipment, cranes, earthmoving equipment & industrial lift trucks. By providing equipment rental, sales, & on-site parts, repair & maintenance functions under one roof, the Company is a one-stop provider for its customers’ varied equipment needs. This full service approach provides the Company with multiple points of customer contact, enabling it to maintain a high quality rental fleet, as well as an effective distribution channel for fleet disposal & provides cross-selling opportunities among its new & used equipment sales, rental, parts sales & service operations. “

HopFed Bancorp (NASDAQ:HFBC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “HopFed Bancorp, Inc. was incorporated for the purpose of serving as a savings and loan holding company for Hopkinsville Federal Savings Bank. The business of the bank primarily consists of attracting deposits from the general public and investing such deposits in loans secured by single family residential real estate and investment securities, including U.S. Government and agency securities and mortgage-backed securities. The bank also originates single-family residential/construction loans and multi-family and commercial real estate loans. “

Health Insurance Innovations (NASDAQ:HIIQ) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “

H. Lundbeck A/S- (NASDAQ:HLUYY) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington’s, epilepsies, Alzheimer’s and Parkinson’s diseases. The Company is involved in the development of new and improved drugs for the treatment of psychiatric and neurological disorders. H. Lundbeck A/S is headquartered in Copenhagen, Denmark. “

Hoya Corp. (OTCMKTS:HOCPY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Hoya Corporation is a specialty manufacturer of optical glass. The Company’s business activities include information technology, eye care, medical, and imaging systems. Its information technologies products include mask blanks and photomasks for semiconductor and LCD, glass memory disks, optical lenses, laser equipment and glass for electronic materials. Its eye care segment includes eyeglass lenses, contact lenses and intraocular lenses while the medical segment includes endoscopic imaging devices and hydroxyapatite. The Company’s imaging system offers digital cameras and CCTV lenses. It also offers system architecture, crystal products, surveying instruments. Hoya Corporation is based in Tokyo, Japan. “

Hanwha Q CELLS Co. (NASDAQ:HQCL) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Hanwha Q CELLS Co., Ltd. is a photovoltaic manufacturer for solar cells and modules. The company offers the full spectrum of photovoltaic products, applications and solutions, from modules to kits to systems to large scale solar power plants. It operates primarily in Europe, North America, Asia, South America, Africa and the Middle East. Hanwha Q CELLS Co. Ltd., formerly known as Hanwha SolarOne Co. Ltd., is headquartered in Seoul, South Korea. “

Heron Therapeutics (NASDAQ:HRTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA. “

Ichor Holdings (NASDAQ:ICHR) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Ichor Holdings, Ltd. is engaged in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment. Ichor Holdings, Ltd. is based in Fremont, United States. “

IEC Electronics Corp (NYSE:IEC) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “IEC Electronics Corp. is a full service, ISO 9001 and 9002 certified, contract manufacturer employing state-of-the-art production utilizing both surface mount and pin-through-hole technology. IEC offers its customers a wide range of manufacturing and management services, on either a turnkey or consignment basis, including design prototyping, material procurement and control, concurrent engineering services, manufacturing and test engineering support, statistical quality assurance and complete resource management. (PRESS RELEASE) “

Intercontinental Hotels Group (NYSE:IHG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “InterContinental Hotels Group offers information and reservations capability on the Internet for InterContinental Hotels & Resorts, Crowne Plaza Hotels & Resorts, Holiday Inn hotels, Holiday Inn Express hotels, and Staybridge Suites by Holiday Inn hotels. “

Ihi Corporation (NASDAQ:IHICY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “IHI Corp. engages in the design, manufacture, sale, installation, repair, overhaul and maintenance of heavy machinery. Resources, Energy and Environment segment includes boilers, power systems, motors for land and marine use, gas processes. Social Infrastructure and Offshore Facility segment handles bridges, water gates, shield tunneling machines, transportation systems, urban development, floating liquefied natural gas storage facilities and offshore structures. Industrial System and General-Purpose Machinery segment offers marine machinery, logistics systems, materials handling equipment, parking systems, steel manufacturing equipment, industrial machinery, heat and surface treatment, papermaking machinery, vehicular turbochargers and compressors, construction machinery and agricultural equipment. Aero Engine, Space and Defense segment deals with aero engines, rocket systems, space utilization systems and defense systems. Others segment includes inspection and measurement business. IHI Corp. is headquartere “

II-VI (NASDAQ:IIVI) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “II-VI Incorporated designs, manufactures and markets optical and opto-electronic components, devices and materials for infrared, near-infrared, visible light, x-ray and gamma ray instrumentation. The Company’s infrared optics business manufactures optical and opto-electronic components sold under the II-VI brand name and used primarily in CO2 lasers. The Company’s near-infrared optics business manufactures near-infrared & visible light products for industrial, scientific, military & medical instruments and laser gain materials and products for solid-state YAG and YLF lasers at the Company’s VLOC subsidiary. The Company’s military infrared optics business manufactures infrared products for military applications under the Exotic Electro-Optics brand name. “

IRHYTHM TECH (NASDAQ:IRTC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. “

Investar Holding Corporation (NASDAQ:ISTR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Investar Holding Corporation is a bank holding company for Investar Bank. It offers a range of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses and professional concerns, as well as loans to individuals. The company accepts various deposit products, including savings, checking, money market, and NOW accounts, as well as various certificates of deposit and individual retirement accounts. It also provides cash management products and services, such as remote deposit capture, electronic statements, positive pay, ACH origination and wire transfer, investment sweep accounts, and business Internet banking, as well as debit cards and mobile banking services. Investar Holding Corporation is headquartered in Baton Rouge, Louisiana. “

Iteris (NYSE:ITI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Iteris, Inc. is a leading provider of outdoor vision systems and sensors that optimize the flow of traffic and enhance driver safety. Iteris combines outdoor image processing, traffic engineering, and information technology to offer a broad range of transportation and safety solutions. “

JD.com (NASDAQ:JD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “JD.com, Inc. operates as an online direct sales company in China. The Company, through its Website www.jd.com and mobile applications offers a selection of authentic products. It offers computers; mobile handsets and other digital products, home appliances; automobile accessories; clothing and shoes; luxury goods including handbags, watches and jewelry, furniture and household products; cosmetics and other personal care items; food and nutritional supplements; books, e-books, music, movies and other media products; mother and childcare products; toys, sports and fitness equipment; and virtual goods. JD.com, Inc. is based in Beijing, China. “

Jounce Therapeutics (NASDAQ:JNCE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company’s lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States. “

Kobe Steel (NASDAQ:KBSTY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Kobe Steel, Ltd. is a steel manufacturer. The Iron and Steel segment manufactures and sells steel bars, stainless-steel products and titanium products. The company offers welding materials, welding robots, and conducts welding-related consulting business. The Aluminum and Copper segment offers rolled aluminum products, rolled copper products, aluminum alloy products, magnesium alloy products and others. The Machinery segment manufactures and sells various energy, chemical and nuclear power-related equipment. The Engineering segment conducts engineering works and provides new transportation systems. The Kobelco Eco-Solutions provides water treatment plants, chemical and food-related equipment. The Kobelco Construction Machinery segment offers hydraulic and mini excavators. The Kobelco Crane segment provides crawler cranes and rough terrain cranes. The others segment develops and leases real estate. “

Kion Group Ag (NASDAQ:KIGRY) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “KION Group AG is a manufacturer of industrial trucks, producer of forklifts as well as warehouse automation. The company designs, builds and supports logistics solutions. KION Group AG is based in Wiesbaden, Germany. “

Kindred Biosciences (NASDAQ:KIN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. “

Kumba Iron Ore (NASDAQ:KIROY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Kumba Iron Ore Limited engages in the exploration, extraction, beneficiation, marketing, shipping, and sale of iron ore in South Africa. Its mining assets and natural resources also include platinum group metals and diamonds, copper, iron ore, metallurgical coal, nickel and thermal coal. The company has mines in various places like Thabazimbi in Limpopo, Sishen in Northern Cape; and Kolomela mine. It also transports iron ore to its customers in Europe and Asia. Kumba Iron Ore Limited is headquartered in Centurion, South Africa. “

KKR & Co. L.P. (NYSE:KKR) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “Kohlberg Kravis Roberts & Co. provides a range of asset management services to its investors and provides capital markets services to its firm, its portfolio companies and its clients. The Company operates private equity funds that take either controlling or strategic minority ownership positions for long-term appreciation; invests in leveraged loans, high-yield bonds and less liquid credit products; and, on behalf of portfolio companies, arranges equity and debt financing and offers capital market advice. Kohlberg Kravis Roberts & Co. is based at New York, New York. “

Receive News & Ratings for Galmed Pharmaceuticals Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galmed Pharmaceuticals Ltd and related companies with MarketBeat.com's FREE daily email newsletter.